Harout Semerjian
Algemeen Directeur bij GLYCOMIMETICS, INC.
Vermogen: 6 775 $ op 31-05-2024
Profiel
Harout Semerjian is currently the President, Chief Executive Officer & Director at GlycoMimetics, Inc. He is also a Director at Biotechnology Innovation Organization.
Previously, he served as the President, Chief Executive Officer & Director at Immunomedics, Inc. in 2020.
From 2018 to 2020, he held the position of Chief Commercial Officer & Executive VP at Ipsen SA and Ipsen Pharma SAS.
Mr. Semerjian holds an MBA from Queen's University and Cornell University.
He completed his undergraduate degree at Lebanese American University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GLYCOMIMETICS, INC.
0.04% | 15-03-2024 | 25 000 ( 0.04% ) | 6 775 $ | 31-05-2024 |
Actieve functies van Harout Semerjian
| Bedrijven | Functie | Begin |
|---|---|---|
| GLYCOMIMETICS, INC. | Algemeen Directeur | 06-08-2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Bestuurslid | 01-10-2023 |
Eerdere bekende functies van Harout Semerjian
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOMEDICS, INC. | Algemeen Directeur | 27-05-2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Corporate Officer/Principal | 30-04-2020 |
| IPSEN | Corporate Officer/Principal | 01-04-2020 |
Opleiding van Harout Semerjian
| Cornell University | Masters Business Admin |
| Queen's University | Masters Business Admin |
| Lebanese American University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IPSEN | Health Technology |
| GLYCOMIMETICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
